403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Purpleai Announces Advisory Engagement With Joshua N. Goldstein, MD, Phd
(MENAFN- EIN Presswire) EINPresswire/ -- PurpleAI, a company focused on advancing data-driven intelligence in stroke and neurocritical care, announced that Joshua N. Goldstein, MD, PhD, has joined the company as a scientific advisor.
Dr. Goldstein is Professor of Emergency Medicine at Harvard Medical School, Vice Chair for Faculty Affairs in the Department of Emergency Medicine at Mass General Brigham in Boston, and Director of the Center for Neurologic Emergencies in the Department of Emergency Medicine at Massachusetts General Hospital. His academic and clinical work focuses on neurologic emergencies, including acute stroke and spontaneous intracerebral hemorrhage, with an emphasis on early risk identification and outcomes research.
In his advisory capacity, Dr. Goldstein will provide high-level scientific and clinical guidance related to stroke and neurocritical care research directions. His role is limited to non-operational, non-promotional advisory activities and is conducted in accordance with applicable institutional policies. Dr. Goldstein noted“I look forward to working with PurpleAI to improve the early diagnosis and management of patients with stroke and intracranial hemorrhage.”
PurpleAI stated that the advisory engagement is intended to support thoughtful alignment between clinical research insights and future scientific exploration in stroke care, while maintaining independence of academic and institutional responsibilities.
Affiliations are listed for identification purposes only and do not imply institutional endorsement.
Dr. Goldstein is Professor of Emergency Medicine at Harvard Medical School, Vice Chair for Faculty Affairs in the Department of Emergency Medicine at Mass General Brigham in Boston, and Director of the Center for Neurologic Emergencies in the Department of Emergency Medicine at Massachusetts General Hospital. His academic and clinical work focuses on neurologic emergencies, including acute stroke and spontaneous intracerebral hemorrhage, with an emphasis on early risk identification and outcomes research.
In his advisory capacity, Dr. Goldstein will provide high-level scientific and clinical guidance related to stroke and neurocritical care research directions. His role is limited to non-operational, non-promotional advisory activities and is conducted in accordance with applicable institutional policies. Dr. Goldstein noted“I look forward to working with PurpleAI to improve the early diagnosis and management of patients with stroke and intracranial hemorrhage.”
PurpleAI stated that the advisory engagement is intended to support thoughtful alignment between clinical research insights and future scientific exploration in stroke care, while maintaining independence of academic and institutional responsibilities.
Affiliations are listed for identification purposes only and do not imply institutional endorsement.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment